Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 87
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/6/2008
 
First Published:
6/23/2004
1.
Phase IV Randomized Study of Rasburicase Alone Versus Rasburicase and Allopurinol Versus Allopurinol Alone in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Closed
18 and over
Pharmaceutical / Industry
PROLOGUE-EFC4978
UCLA-0403071-01, NCT00230178
2.
Phase II/III Consolidation Chemotherapy with VP-16/AMSA/AZC Following Induction with DNM/ARA-C/TG for Adult Primary or Secondary Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 and over
NCI-D82-051-605
Last Modified:
8/10/2007
3.
Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
under 21
NCI
CCG-192P
Last Modified:
11/9/2005
4.
Phase II/III Randomized Study of Standard-Dose vs High-Dose MTX Followed by Induction and Continuation for Patients with ALL or AUL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
DFCI-81001
NCI-D82-018-0400, D82-018-0400
Last Modified:
5/23/2007
5.
Phase III Pilot Intensification with High-Dose ARA-C and Consolidation with MACHO (CTX/ADR/VCR/PRED/MTX/L-ASP) for Adult ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
15 to 65
NCI
EST-2483
6.
Phase III Chemotherapy with 5-FU and Allopurinol vs 5-FU Alone for Previously Untreated Metastatic Colorectal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
SEG-GI-82389
Last Modified:
4/1/1997
7.
Phase III Pre- and Postoperative Combination Chemotherapy Including High-Dose MTX in Children with Previously Untreated Nonmetastatic Osteogenic Sarcoma of an Extremity (Summary Last Modified 04/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
2 to 21
NCI
CCG-782
8.
Phase III Intensive Reinduction Followed by Intensive Maintenance vs Conventional Maintenance Chemotherapy in Relapsed Childhood ALL and AUL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
21 and under
NCI
NCI-82-C-199
NCI-POB-7709, NCI-T83-0966N, T83-0966
Last Modified:
6/18/2007
9.
Phase III Total Sanctuary vs Conventional CNS Treatment for Newly Diagnosed Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
under 21
NCI
CCG-191
NCI-82-C-200, NCI-POB-7702
Last Modified:
6/28/2004
10.
Phase III Randomized Comparison of Chemotherapy with CHOP (CTX/ADR/VCR/PRED) Alone vs CHOP plus Radiotherapy Consolidation for Unfavorable Early Stage non-Hodgkin's Lymphoma (Summary Last Modified 09/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
16 and over
NCI
EST-1484
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute